Revising Adult RSV Policy: US CDC Moves Toward Risk-Based Vaccine Recommendation

 
• By Bridget Silverman
  
RSV Vaccine
The ACIP work group said to recommend GSK's RSV vaccine for adults age 60-74 at increased risk of severe disease. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet